To study this hypothesis we analyzed NSCLC patients screened for the presence of EGFR and KRAS mutations in a diagnostic setting and investigated whether the presence of EGFR and KRAS mutations in NSCLC patients was related to COPD. The gene discussed is KRAS; the disease is chronic obstructive pulmonary disease.